Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:21 p.m.

    📋 Intercept Pharmaceuticals, Inc. (ICPT) - Financial Results

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 07:00:32

    Event Type: Financial Results

    Event Details:

    Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT) Reports Q3 2022 Financial Results Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 325000
    • Net Income: 0.43
    • EPS: Not disclosed
    • Cash and equivalents: 412313

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 43.88K 77.74K $-33.86K -43.55%
    Other Income Expense Interest Expense 12.59K 13.34K $-753.00 -5.64%
    Other Income Expense Net Loss 11.09K 24.81K $-13.72K -55.29%
    Net Incomeloss Per Common And Potential Common Share Net Loss 0.33 0.83 $-0.50 -60.24%
    Revenue 68.18K 130.90K $-62.73K -47.92%
    Selling, General & Administrative 43.88K 77.74K $-33.86K -43.55%
    Interest Expense 12.59K 13.34K $-753.00 -5.64%
    Net Loss 11.09K 24.81K $-13.72K -55.29%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023)
    • CIK: 0001270073
    • Ticker Symbol: ICPT
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories